India-Brazil trade expansion to $30 billion
Analysis based on 11 articles · First reported Aug 31, 2026 · Last updated Aug 31, 2026
The commitment to expand bilateral trade to $30 billion by 2030 signals stronger economic ties between India and Brazil, potentially boosting trade flows and investment in sectors like pharmaceuticals and agriculture. Market sentiment is positive for companies in these sectors, though the impact is moderate given the long-term nature of the target.
India and Brazil co-chaired the 8th Trade Monitoring Mechanism meeting in Brasilia on August 31, 2026, committing to expand bilateral trade to USD 30 billion by 2030. The meeting reviewed trade performance, which reached USD 15.07 billion in 2025-26, and identified pharmaceuticals, chemicals, engineering goods, and machinery as priority sectors. Both sides committed to early finalisation of the India-Mercosur Terms of Reference to modernise the Preferential Trade Agreement, with bilateral trade with Mercosur reaching USD 20.84 billion in 2025. On pharmaceuticals, they emphasised greater market access for Indian products, anchored by the India — Central Drugs Standard Control Organisation-Brazil — Brazilian Health Regulatory Agency memorandum of understanding signed in February 2026. Progress was made on mutual recognition of electronic certificates of origin and cooperation on MSMEs. Both nations reaffirmed coordination under the WTO, G20, and BRICS. An India-Brazil High Level Business Reception was held, with an Indian delegation of over 25 companies including Kirloskar Group, UPL Limited, and Aditya Birla Group. Both sides welcomed the establishment of an Brazil — Apex-Brasil office in New Delhi to boost investment.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard